GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis

Conclusion: GPRC5A may act as an oncogene in the progression of PaCa and could be a prognostic biomarker in predicting survival of PaCa.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Xuetian Qian, Chengfei Jiang, Shanshan Shen, Xiaoping Zou Tags: Research Paper Source Type: research